Circularis Biotechnologies careers

​CIRCULARIS HAS DEVELOPED A VERY POWERFUL AND NOVEL METHOD TO REGULATE GENE EXPRESSION AND ENABLE INCREASED BIOTHERAPEUTIC PRODUCTION YIELDS UP TO 10X OR MORE. WE CAN DO THIS FOR ANY GENE, IN ANY SPECIES, WITH NO PRIOR KNOWLEDGE OF THE REGULATORY ELEMENTS OR CODING SEQUENCE.

$85B patent cliff on biologics is creating top down pressure on profitability. All biotherapeutic manufacturers desperately need to reduce their cogs to survive in a biosimilar world. Circularis is the ONLY company that can deliver optimized gene expression and increased production yields for any protein from any species with no prior knowledge of regulatory or coding sequence.